论文部分内容阅读
目的进一步规范非小细胞肺癌的诊断,为其治疗和判断预后提供依据。方法统计2002年2月至2005年8月沈阳军区总医院接受治疗的146例非小细胞肺癌的诊断结果。结果总体有完整病理诊断的123例,占84·2%。其中经手术获得病理诊断的42例,占28·8%;未手术的104例中,经痰细胞学检查、淋巴结针吸活检、胸腔积液细胞学和支气管镜获得诊断的分别为31例(21·2%)、18例(12·3%)、15例(10·3%)和11例(7·5%)。经临床诊断(无明确病理诊断,依据临床体征和影像学检查)的23例,占15·7%。结论在治疗前对非小细胞肺癌作出明确的病理诊断,会使治疗更准确无误,对判定肿瘤的发展和预后更有帮助。
Objective To further standardize the diagnosis of non-small cell lung cancer and provide the basis for its treatment and prognosis. Methods The diagnostic results of 146 cases of non-small cell lung cancer treated in Shenyang General Hospital from February 2002 to August 2005 were collected. Results There were 123 cases with complete pathological diagnosis, accounting for 84.2%. Among them, 42 cases were pathologically diagnosed by surgery, accounting for 28.8%. Of the 104 cases without surgery, 31 cases were diagnosed by sputum cytology, lymph node biopsy, pleural effusion cytology and bronchoscopy respectively 21.2%), 18 cases (12.3%), 15 cases (10.3%) and 11 cases (7.5%). After clinical diagnosis (no definite pathological diagnosis, based on clinical signs and imaging examination) of 23 cases, accounting for 15.7%. Conclusions The definite pathological diagnosis of non-small cell lung cancer before treatment will make the treatment more accurate and accurate, which is more helpful to judge the development and prognosis of the tumor.